Fig. 2From: Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancerCompeting risk regression of local relapse (a), locoregional relapse (b), local relapse as a function of relapse location (c), locoregional relapse as a function of tumor coverage (d)Back to article page